Clinical Trial Update: Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding magnesium sulfate to bupivacaine for ilioinguinal and iliohypogastric nerve block has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iliohypogastric Neuralgia
• Ilioinguinal Neuralgia
• Postoperative Pain Management

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Abdelrady S Ibrahim, MD | Conditions: Magnesium Sulfate Causing Adverse Effects in Therapeutic Use | Phase 2 | Status: COMPLETED